Chemomab Therapeutics (CMMB) Pension (2017 - 2019)

Chemomab Therapeutics' (CMMB) quarterly Pension came in at $10000.0 in Q3 2019, little changed on a QoQ basis from $10000.0 in Q2 2019.

Chemomab Therapeutics (CMMB) Pension (2017 - 2019) Analysis & Trends

Chemomab Therapeutics (CMMB) has 3 years of Pension data on file, last reported at $10000.0 in Q3 2019.

Quarterly Pension changed N/A year-over-year to $10000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $10000.0 (changed N/A YoY) and the FY2018 annual result came in at $210000.0, up 6900.0% from the prior year.
Pension was little changed at $10000.0 in Q3 2019, from $10000.0 in the prior quarter.
In the past five years, Pension ranged from a high of $210000.0 in Q4 2018 to a low of $3000.0 in Q4 2017.
A 3-year average of $58250.0 and a median of $10000.0 in 2019 frame the typical range for Pension.
The widest YoY moves for Pension: up 6900.0% in 2018, down 6900.0% in 2018.
Tracing CMMB's Pension over 3 years: stood at $3000.0 in 2017, then jumped by 6900.0% to $210000.0 in 2018, then slumped by 95.24% to $10000.0 in 2019.
The last three Pension figures came in at $10000.0 (Q3 2019), $10000.0 (Q2 2019), and $210000.0 (Q4 2018), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Chemomab Therapeutics	13.33 Mn	2.96 Mn	-

Download Data